Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers.
about
Polymer-drug conjugates: origins, progress to date and future directionsSynthesis and characterization of biodegradable HPMA-oligolysine copolymers for improved gene deliveryInduction of systemic antitumour resistance with targeted polymers.Anticancer carrier-linked prodrugs in clinical trials.Design, synthesis and applications of hyaluronic acid-paclitaxel bioconjugates.Engineered polymers for advanced drug delivery.Beyond oncology--application of HPMA copolymers in non-cancerous diseases.Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.Riboflavin-targeted polymer conjugates for breast tumor delivery.Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systems.Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.The Light at the End of the Tunnel-Second Generation HPMA Conjugates for Cancer Treatment.
P2860
Q27002505-84820D9B-2516-41E5-8807-CDAB8608CA6EQ33601685-B22697F0-908B-4BD5-9A6B-5EB1A37514D3Q36161514-34C63FA6-078C-4F0B-AFCF-E81C1B760EBAQ36861603-C238DA13-8AAE-4182-A3E5-458B7C78AD0DQ37096500-7158F5E6-AEE7-4C2C-9595-95514D04F315Q37314701-5F796CCB-E210-4721-9FFA-FC0810C095C7Q37631869-FF13A577-D7FD-4DF8-A185-4C2C0167DECAQ38038897-18AE3689-4F22-4650-8986-02E12F69ABC1Q38626421-AB14F4E0-E972-4E71-AD7D-45C0959A75C4Q39169209-48FB716F-1F9D-4CD6-8177-BEEE85E1A144Q42170543-B959454A-DEF4-4AF1-B602-F538A71A8646Q42551562-29476A03-6A30-418E-8041-DC4A3F0D1EEAQ45204007-56E8C7C6-C806-4D51-A2A0-2804F12CCA81Q48558433-C34E3F6A-D46A-4E67-958C-46EF08BB3AB3
P2860
Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers.
@ast
Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers.
@en
type
label
Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers.
@ast
Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers.
@en
prefLabel
Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers.
@ast
Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers.
@en
P356
P1476
Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers.
@en
P2093
P304
P356
10.2174/1389201033489711
P577
2003-10-01T00:00:00Z